Resources
Investigate and explore as you develop an understanding of MS and its accompanying symptoms.
Progressive Multiple Sclerosis
This article provides an update on progressive forms of multiple sclerosis (MS) commonly referred to as primary progressive MS and secondary progressive MS. It discusses the importance of diagnosing and detecting progression early, the similarities between progressive forms, challenges in detecting progression, factors that could augment progression, and the importance of disease-modifying therapies in patients with evidence of active progressive MS. It also discusses the overall care of progressiveMS.
Read MoreEffectiveness of Aquatic Therapy for Individuals With Multiple Sclerosis: A Systematic Review
Multiple sclerosis (MS) is an inflammatory, demyelinating disease that attacks the central nervous system. It is estimated that from 350,000 to 400,000 people in the United States are affected by MS. This study is a systematic review of randomized controlled trials (RCTs) evaluating the benefits of aquatic therapy for people with MS.
Read MorePredicting Disability Worsening in Relapsing and Progressive Multiple Sclerosis
Multiple sclerosis (MS) is a clinically heterogeneous disease, which complicates expectant management as well as treatment decisions. This review provides an overview of both well established and emerging predictors of disability worsening, including clinical factors, imaging factors, biomarkers and treatment strategies.
Read MoreCOVID-19 among Patients with Multiple Sclerosis
We systematically reviewed the literature on COVID-19 in patients with multiple sclerosis (MS). We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, Google Scholar, and World Health Organization database from December 1, 2019, to December 18, 2020. Three conference abstract databases were also searched. We included any types of studies that reported characteristics of patients with MS with COVID-19.
Read MoreUptake and Attitudes About Immunizations in People with Multiple Sclerosis
By surveying a multiple sclerosis (MS) population, we tested the hypothesis that influenza vaccine uptake would not meet public health targets and that vaccine misconceptions would contribute to lower than desired uptake.
Read More